CRL
Charles River Laboratories International Inc.

915
Mkt Cap
$9.6B
Volume
515,160.00
52W High
$199.66
52W Low
$91.86
PE Ratio
-124.14
CRL Fundamentals
Price
$193.03
Prev Close
$194.43
Open
$194.37
50D MA
$177.32
Beta
1.38
Avg. Volume
1.13M
EPS (Annual)
$0.1994
P/B
2.79
Rev/Employee
$201,491.99
Loading...
Loading...
News
all
press releases
Charles River Laboratories International (NYSE:CRL) Stock Rating Lowered by Wall Street Zen
Wall Street Zen lowered Charles River Laboratories International from a "buy" rating to a "hold" rating in a research report on Saturday...
MarketBeat·12m ago
News Placeholder
More News
News Placeholder
Sei Investments Co. Buys 39,959 Shares of Charles River Laboratories International, Inc. $CRL
Sei Investments Co. lifted its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 5.9% during the 2nd quarter, according to its most recent disclosure with the...
MarketBeat·20h ago
News Placeholder
Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort
Charles River Laboratories International, Inc. (NYSE: CRL) today announced the second cohort of its Cell & Gene Therapy Incubator Program (CIP). Launched in December 2024, with the inaugural cohort...
Business Wire·2d ago
News Placeholder
What's Driving the Market Sentiment Around Charles River Laboratories International Inc?
read more...
Benzinga·3d ago
News Placeholder
Charles River Laboratories International, Inc. $CRL Shares Acquired by Bank of Nova Scotia
Bank of Nova Scotia lifted its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 10,860.5% in the second quarter, according to its most recent 13F...
MarketBeat·4d ago
News Placeholder
Invesco Ltd. Purchases 128,785 Shares of Charles River Laboratories International, Inc. $CRL
Invesco Ltd. raised its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 11.6% during the second quarter, according to its most recent filing with the SEC. The...
MarketBeat·5d ago
News Placeholder
Russell Investments Group Ltd. Buys 11,667 Shares of Charles River Laboratories International, Inc. $CRL
Russell Investments Group Ltd. increased its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 59.8% in the second quarter, according to the company in its most...
MarketBeat·6d ago
News Placeholder
Burgundy Asset Management Ltd. Buys 277,450 Shares of Charles River Laboratories International, Inc. $CRL
Burgundy Asset Management Ltd. grew its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 10,200.4% during the second quarter, according to its most recent 13F...
MarketBeat·6d ago
News Placeholder
Norges Bank Makes New Investment in Charles River Laboratories International, Inc. $CRL
Norges Bank purchased a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) during the second quarter, according to its most recent Form 13F filing with the...
MarketBeat·8d ago
News Placeholder
Charles River Laboratories International, Inc. (NYSE:CRL) Receives Average Recommendation of "Moderate Buy" from Brokerages
Charles River Laboratories International, Inc. (NYSE:CRL - Get Free Report) has received an average recommendation of "Moderate Buy" from the eighteen ratings firms that are covering the company...
MarketBeat·9d ago

Latest CRL News

View

Advertisement|Remove ads.

Advertisement|Remove ads.